Below is a lost of our current member programs and programs of work. They currently span over 20 different tumour types across 13 countries. These programs range in structure from established genomic oncology platforms, nationwide personalised medicine strategies, regulatory clinical trials, and global tumour consortia. Select a program below to learn more about the study.
North America
BC Cancer Personalised OncoGenics Program
Weill Cornell Cancer Precision Medicine Program
Pancreatic Cancer Harmonized "Omics" analysis for Personalized Treatment
Europe
Swiss Oncology and Cancer Immunology Breakthrough Platform
European Peripheral T-cell lymphoma Study (EuroTCLym)
Profiling Orphan Neoplasms for Treatment Election
CRUK Grand Challenge – Mutographs
Interdisciplinary molecular and immunologic PDAC consortium Erlangen
Non-Melanoma Skin Cancer Genomics
Asia
Korea Multiple Myeloma Precision Medicine Project
Personalised Genomic Characterisation of Korean Lung Cancers
Korea Rare, Young Age and Drug Resistant Cancer Study
Genomic Medicine for Asia-Prevalent Cancers
Clinical Genomic Study of Colorectal Cancer in China
Genomic and Proteomic Characterisation of Gastric Cancer
Oesophageal Squamous Cell Carcinoma Study
Genomics of Brain Metastasis Project
Multicenter Study to Profile and Monitor Cancer-related Genomic Alterations in Circulating Tumor DNA and Gut Microbiome in Advanced Solid Malignancies
Multicenter Study on Biomarker Development Utilizing AI Multiomics for Patients with Advanced Solid Malignant Tumors
Multiple Cancers / Pan Cancer
Middle East
Papillary Thyroid Cancer Project
United Kingdom
Pan Prostate Cancer Group
OCCAMS: Oesophageal Cancer Clinical and Molecular Stratification
Personalised Breast Cancer Program
Oceania
Australian Pancreatic Genome Initiative